CYP3A5 and UGT1A9 Polymorphisms Influence Immunosuppressive Therapy in Pediatric Kidney Transplant Recipients.
Krall P, Yañez D, Rojo A, Delucchi Á, Córdova M, Morales J, Boza P, de la Rivera A, Espinoza N, Armijo N, Castañeda LE, Farfán MJ, Salas C.
Krall P, et al. Among authors: farfan mj.
Front Pharmacol. 2021 Apr 22;12:653525. doi: 10.3389/fphar.2021.653525. eCollection 2021.
Front Pharmacol. 2021.
PMID: 33967795
Free PMC article.